Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3711789012 | Product containing rivastigmine in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3711790015 | Rivastigmine-containing product in transdermal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Rivastigmine-containing product in transdermal dose form | Plays role | Antidementia therapeutic role | true | Inferred relationship | Some | ||
Rivastigmine-containing product in transdermal dose form | Is a | Antidementia agent | true | Inferred relationship | Some | ||
Rivastigmine-containing product in transdermal dose form | Has manufactured dose form | Transdermal dose form | true | Inferred relationship | Some | ||
Rivastigmine-containing product in transdermal dose form | Has active ingredient | Rivastigmine | true | Inferred relationship | Some | 1 | |
Rivastigmine-containing product in transdermal dose form | Is a | Product manufactured as transdermal dose form | true | Inferred relationship | Some | ||
Rivastigmine-containing product in transdermal dose form | Is a | Rivastigmine-containing product | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Rivastigmine only product in transdermal dose form | Is a | True | Rivastigmine-containing product in transdermal dose form | Inferred relationship | Some | |
Rivastigmine 9.5mg/24 hours transdermal patch | Is a | False | Rivastigmine-containing product in transdermal dose form | Inferred relationship | Some | |
Rivastigmine 4.6mg/24 hours transdermal patch | Is a | False | Rivastigmine-containing product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets